SCHEMBL336074

SCHEMBL336074

O=C1[N]C=NC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4357232 0.67
SCHEMBL6742872 0.64
SCHEMBL8625587 0.58
SCHEMBL8621147 0.58
SCHEMBL10751007 0.58
SCHEMBL432911 0.58
SCHEMBL11001832 0.57
SCHEMBL1428214 0.50
SCHEMBL72400 0.48
SCHEMBL29525411 0.48 KDM4E (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200353107-A1 IN VIVO IMAGING OF TUMOR INFILTRATION LEUKOCYTES STC UNM (US) 2020-11-12 US disclosed
US-10744214-B2 Method of diagnosing and/or monitoring therapy of atherosclerosis STC.UNM (US) 2020-08-18 US disclosed
US-10548994-B1 Control of chronic neuropathic pain and allodynia STC.UNM (US) 2020-02-04 US disclosed
WO-2019113449-A1 IN VIVO IMAGING OF TUMOR INFILTRATION LEUKOCYTES STC.UNM (US) 2019-06-13 WO disclosed
US-20180369430-A1 METHOD OF DIAGNOSING AND/OR MONITORING THERAPY OF ATHEROSCLEROSIS UNM RAINFOREST INNOVATIONS 2018-12-27 US disclosed
WO-2017117199-A1 METHOD OF DIAGNOSING AND/OR MONITORING THERAPY OF ATHEROSCLEROSIS STC.UNM (US) 2017-07-06 WO disclosed
US-9546186-B2 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma STC.UNM (US) 2017-01-17 US disclosed
US-20160324993-A1 NON-INVASIVE DIAGNOSTIC AGENTS OF CANCER AND METHODS OF DIAGNOSING CANCER, ESPECIALLY LEUKEMIA AND LYMPHOMA STC UNM (US) 2016-11-10 US disclosed
US-20160287728-A1 NON-INVASIVE DIAGNOSTIC AGENTS AND METHODS OF DIAGNOSING INFECTIOUS DISEASE STC UNM (US) 2016-10-06 US disclosed
US-9352059-B2 Non-invasive diagnostic agents and methods of diagnosing infectious disease STC.UNM (US) 2016-05-31 US disclosed
US-8834838-B2 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma STC.UNM (US) 2014-09-16 US disclosed
US-20140086833-A1 NON-INVASIVE DIAGNOSTIC AGENTS AND METHODS OF DIAGNOSING INFECTIOUS DISEASE THE REGENTS OF THE UNIVERSITY OF NEW MEXICO 2014-03-27 US disclosed
US-8623322-B2 Non-invasive diagnostic agents and methods of diagnosing infectious disease STC.UNM (US) 2014-01-07 US disclosed
US-20130216478-A1 Non-Invasive Diagnostic Agents of Cancer and Methods of Diagnosing Cancer, Especially Leukemia and Lymphoma NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-08-22 US disclosed
US-8435489-B2 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma STC.UNM (US) 2013-05-07 US disclosed
US-20120070372-A1 NON-INVASIVE DIAGNOSTIC AGENTS OF CANCER AND METHODS OF DIAGNOSING CANCER, ESPECIALLY LEUKEMIA AND LYMPHOMA STC.UNM (US) 2012-03-22 US disclosed
US-8097237-B2 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma STC.UNM (US) 2012-01-17 US disclosed
US-20110117014-A1 NON-INVASIVE DIAGNOSTIC AGENTS AND METHODS OF DIAGNOSING INFECTIOUS DISEASE THE REGENTS OF THE UNIVERSITY OF NEW MEXICO C/O RESEARCH & TECHNOLOGY LAW 2011-05-19 US disclosed
WO-2009151646-A2 NON-INVASIVE DIAGNOSTIC AGENTS AND METHODS OF DIAGNOSING INFECTIOUS DISEASE STC.UNM (US) 2009-12-17 WO disclosed
US-20070048216-A1 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-03-01 US disclosed